Streptococcus pneumoniae Nasopharyngeal Colonization and Antibiogram of Isolates from Paediatric Population in Enugu, South East Nigeria

Clara Idara Eleazar

Department of Microbiology, Faculty of Biological Sciences, University of Nigeria, Nsukka, Nigeria.

Iniekong Philip Udoh *

Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Nigeria, Nsukka, Nigeria.

Uzomaka Charity Madaukor

Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Nigeria, Nsukka, Nigeria.

Veronica Ngozi Emenuga

Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Nigeria, Nsukka, Nigeria.

Rita Ngozi Nweke

Department of Microbiology, Faculty of Biological Sciences, University of Nigeria, Nsukka, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Aims: This research aimed to evaluate and identify Streptococcus pneumoniae from nasopharynx samples of children and carry out antibiotic susceptibility assay on the isolates; being that pneumococci is well noted as a significant cause of invasive pneumonia in infants with the challenge of antibiotic resistance, which may worsen due to the emergence of such strains among children population.

Methodology: This was a descriptive, cross-sectional study conducted between March and September 2023 in the Nsukka area of Enugu. Samples were collected from 100 children population using sterile swab sticks. These were inoculated unto blood and chocolate agar and then incubated at 37o C, morphological and biochemical characteristics were used for identification. An antimicrobial susceptibility test using the disk diffusion method was performed on isolates. The multi-discs used were pefloxacin 10ug, Gentamicin 10ug, Ampiclox 30ug, Cefuroxime 20ug, Amoxacillin 30ug, Ceftriazone 25ug, Ciprofloxacin 10ug, and Streptomycin 30ug, Co-tirmoxazole 30ug, and, Erythromycin 10ug.

Results: The results identified 8.0% of pediatric with pneumococcal carriage. Males were 10.0% while females were 5.0%. The age distributions were as follows: 0-5 years 4(8.7%), 6-10 years 1(3.1%), 11-15 years, 3(13.6%). There was no significant difference in the age range distribution of the pneumococci colonization (p=0.074). There was 66.7% sensitivity rate of S. pneumonia. The resistant rates were 75% each to Ampiclox and Amoxicillin. Cefuroxime was 87.5% resistant.

Keywords: Streptococcus pneumonia, antibiotics, paediatrics


How to Cite

Eleazar , Clara Idara, Iniekong Philip Udoh, Uzomaka Charity Madaukor, Veronica Ngozi Emenuga, and Rita Ngozi Nweke. 2024. “Streptococcus Pneumoniae Nasopharyngeal Colonization and Antibiogram of Isolates from Paediatric Population in Enugu, South East Nigeria”. International Journal of Pathogen Research 13 (3):6-14. https://doi.org/10.9734/ijpr/2024/v13i3281.

Downloads

Download data is not yet available.

References

Olarte L, Barson WJ, Barson RM, Romero JR, Bradley JS, Tan T Q et al. Pneumococcal pneumonia requiring hospitalization in US children in the 13-valent pneumococcal conjugate vaccine era. Clinical Infectious Diseases. 2017; 64(12):1699–1704 DOI:10.1093/cid/cix115

Loughran AJ, Orihuela CJ, Tuomanen EI Streptococcus pneumoniae: Invasion and inflammation. Microbiology Spectrum. 2019;7(2):10. DOI:10.1128/microbiolspec.GPP3-0004-2018

Wahl B, O'Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, Lukšić I, Nair H, McAllister DA, Campbell H, Rudan I, Black R, Knoll MD. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: Global, regional, and national estimates for 2000-15. Lancet Glob Health. 2018;6(7):e744-e757. DOI:10.1016/S2214-109X(18)30247-X

Kaur R, Morris M, Pichichero ME. Epidemiology of Acute Otitis Media in the Post pneumococcal Conjugate Vaccine Era. Pediatrics. 2017;140(3):e20170181 Available:https://doi.org/10.1542/peds.2017-0181

Trinh NTH, Cohen R, Lemaitre M, Chahwakilian P, Coulthard G, Bruckner TA et al. Community antibiotic prescribing for children in France from 2015 to 2017: A cross-sectional national study. Journal of Antimicrobial Chemotherapy. 2020;75:(8): 2344–2352.

DOI:10.1093/jac/dkaa162

Simell B, Auranen A, Kayhty H, Goldblatt D, Dagan K.L, Brien O, et al. The fundamental link between pneumococcal carriage and disease. Expert rev. Vaccines. 2012;11(7):841-855.

DOI:10.1586/erv.12.53. PMID: 22913260

Zintgraff J, Gagetti P, Napoli D, Sanchez EN, Irazu L, Moscoloni M et al. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine. 2022; 40(3): 459–470.

DOI:10.1016/j.vaccine.2021.12.008

Adetifa IMO, Adamu AL, Karani A, Waithaka M, Odeyemi KA, Okoromah CAN. Nasopharyngeal pneumococcal carriage in Nigeria: A two-site, population-based survey. Scientific Reports. 2018; 8(1):3509.

DOI:10.1038/s41598-018-21837

Løvlie A, Vestrheim DF, Aaberge IS, Steens A. Changes in pneumococcal carriage prevalence and factors associated with carriage in Norwegian children, four years after introduction of PCV13. BMC Infectious Diseases. 2020;20(1):29. DOI:10.1186/s12879-019-4754-0

Tvedskov ESF, Hovmand N, Benfield T, Tinggaard M. Pneumococcal carriage among children in low and lower-middle-income countries: A systematic review. International Journal of Infectious Disease. 2022;1(15):1-7. DOI:10.1016/j.ijid.2021.11.021

Lewnard JA, Givon-Lavi N, Huppert A, Pettigrew MM, Regev-Yochay G. Dagan R, Weinberger DM. Epidemiological markers for inter- actions among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in upper respiratory tract carriage. The Journal of Infectious Disease. 2016;213(10):1596–1605. Available:https://doi.org/10.1093/infdis/jiv761

GBD 2016. Lower Respiratory Infections Collaborators. GBD 2016 lower respiratory infections collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: A systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18:1191–210. DOI:10.1016/S1473-3099(18)30310-4

Kaur R, Casey JR, Pichichero ME. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children after 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006–2015. Journal of Pediatric Infectious Diseases. 2016;35: 901–906. DOI:10.1097/INF.0000000000001206

Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 30th edition (M100). Wayne, PA: Clinical and Laboratory Standards Institute; 2020.

Zhang Z, Chen M, Yu Y, Pan S, Liu Y. Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilusinfluenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Infection and drug Resistance. 2019;12:1209-1220. DOI:10.2147/IDR.S203121

Sharew B, Moges F, Yismaw G, Abebe W, Fentaw S, Vestrheim D. Antimicrobial resistance profile and multi-drug resistance patterns of Streptococcus pneumoniae isolates from patients suspected of pneumococcal infections in Ethiopia. Annals of Clinical Microbiology and Antimicrobials. 2021;20(1):26. DOI:10.1186/s12941-021-00432-z

Cillóniz C, Garcia-Vidal C, Ceccato A, Torres A. Antimicrobial resistance among Streptococcus pneumoniae. Antimicrobial Resistance in the 21st Century. 2018;13-38 DOI: 10.1007/978-3-319-78538-7_2

Straume D, Stamsås GA, Håvarstein LS. Natural transformation and genome evolution in Streptococcus pneumoniae. Infection, Genetics and Evolution. 2015; 33:371-380 Available:https://doi.org/10.1016/j.meegid.2014.10.020

Thummeepak R, Leerach N, Kunthalert D, Tangchaisuriya U, Thanwisai A, Sitthisak S. High prevalence of multi-drug resistant Streptococcus pneumoniae among healthy children in Thailand. Journal of infection and public health. 2015;8(3):274-281. DOI:10.1016/j.jiph.2014.11.002

Littorin N, Ahl J, Uddén F, Resman F, Riesbeck K. Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county. BMC Infectious Diseases. 2016;16: (1)-407. DOI:10.1186/s12879-016-1750-5.

Tran Quang K, Tran Do H, Pham Hung V, Nguyen Vu T, Tran Xuan B, Larsson M, et al. Study on the co-infection of children with severe community-acquired pneumonia. Pediatr Int. 2022;64:e14853.

DOI:10.1111/ped.14853

Marcelo CS, Paulo JCM, Renato TS. Pneumonia in children. In: Wilmott RW, editor. Kendig's Disorders of the Respiratory Tract in Children, 9th ed. Philadelphia: PA: Elsevier. 2018;1597–644.

Cai K, Wang Y, Guo Z, Xu X, Li H, Zhang Q. Clinical characteristics and antimicrobial resistance of pneumococcal isolates of pediatric invasive pneumococcal disease in China. Drug Resistance. 2018;11:2461–2469. DOI: 10.2147/IDR.S183916

Emgård M, Msuya SE, Nyombi BM, Mosha D, Gonzales-Siles L, Nordén R. Carriage of penicillin-non-susceptible pneumococci among children in northern Tanzania in the 13-valent pneumococcal vaccine era. International Journal of Infectious Diseases. 2019;81:156-166. DOI: 10.1016/j.ijid.2019.01.035

Koliou MG, Andreou K, Lamnisos D, Lavranos G, Iakovides P. Economou. Risk factors for carriage of Streptococcus pneumoniae in children. BMC Pediatrics. 2018;18(1):144. DOI:10.1186/s12887-018-1119-6.

Adetifa IMO, Antonio M, Okoromah CAN, Ebruke C, Inem V, Nsekpong D, et al. Pre- Vaccination Nasopharyngeal Pneumococcal Carriage in a Nigerian Population: Epidemiology and Population Biology. Plos One. 2012;7(1):e30548. Available:https://doi.org/10.1371/journal.pone.0030548

Dananché C, Paranhos-Baccal G, Messaoudi M, Sylla , Awasthi S, Bavdekar A, Sanghavi S. et al Serotypes of Streptococcus pneumoniae in Children Aged <5 Years Hospitalized with or without Pneumonia in Developing and Emerging Countries: A Descriptive, Multicenter Study. Clinical Infectious Disease 2020; 70(5) 875-883. DOI:10.1093/cid/ciz277

Daningrat WOD Amalia H, Ayu IM, Satzke C, Safari D. Carriage of Streptococcus pneumoniae in children under five years of age prior to pneumococcal vaccine introduction in Southeast Asia: A systematic review and meta-analysis (2001–2019). Journal of Microbiology, Immunology and Infection. 2022;55(1):6-17. DOI: 10.1016/j.jmii.2021.08.002.

Walekhwa M, Muturi M, Gunturu R, Kenya E, Kabera B. Streptococcus pneumoniae Serotype Epidemiology among PCV-10 Vaccinated and Unvaccinated Children at Gertrude's Children's Hospital, Nairobi County: A Cross-Sectional Study. F1000Res. 2018; 22:(7)879.

DOI:10.12688/f1000research.14387.2

Adamu AL, Ojal J, Abubakar IA, Odeyemi KA, Bello MM, Okoromah CAN, Karia B, Karani A, Akech D, Inem V, Scott JAG, Adetifa IMO. The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria. Nat. Commun. 2023;14(1):2666.

DOI:10.1038/s41467-023-38277-z

Lliyasu G, Habib AG, Mohammad AB. Antimicrobial susceptibility pattern of invasive pneumococcal isolates in North West Nigeria. Journal of Global Infectious Diseases. 2015;7(2):70-74. DOI:10.4103/0974-777X.154440

Tran-Quang K, Nguyen-Thi-Dieu T, Tran-Do H, Pham-Hung V, Nguyen-Vu T, Tran-Xuan B, Larsson M, Duong-Quy S. Antibiotic resistance of Streptococcus pneumoniae in Vietnamese children with severe pneumonia: A cross-sectional study. Front Public Health. 2023;13:11. DOI:10.3389/fpubh.2023.1110903

Mohanty S. Feemster K, Yu C, Watts JA, Gupta V. Trends in Streptococcus pneumoniae Antimicrobial Resistance in US Children: A Multicenter Evaluation. Open Forum Infectious Diseases. 2023; 10(3):ofad098 Available:https://doi.org/10.1093/ofid/ofad098